AFP and hepatocellular carcinoma: In the diagnosis of HBV DNA+/HCC, when PIVKA-II was combined with AFP, the AUROC of PIVKA-II decreased (0.942 versus 0.957, respectively); however, there were no significant differences in AUROCs between combined diagnosis and single diagnosis (P = 0.432).